Optical mammograms were obtained on 7 patients undergoing neoadjuvant chemotherapy. When therapy was 30% complete, patients achieving a high pathologic response had a lower oxy-hemoglobin decrease compared to those with extensive disease remaining.

© 2016 Optical Society of America

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription